Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials (Q40251971)
Jump to navigation
Jump to search
scientific article published on 5 April 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials |
scientific article published on 5 April 2017 |
Statements
1 reference
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials (English)
1 reference
Gregory J Dore
1 reference
Catherine A M Stedman
1 reference
Ira M Jacobson
1 reference
Eric Lawitz
1 reference
Edward J Gane
1 reference
Bernard E Willems
1 reference
Peter J Ruane
1 reference
Ronald G Nahass
1 reference
Sergio M Borgia
1 reference
Stephen D Shafran
1 reference
Kimberly A Workowski
1 reference
Brian Pearlman
1 reference
Robert H Hyland
1 reference
Luisa M Stamm
1 reference
Evguenia Svarovskaia
1 reference
Hadas Dvory-Sobol
1 reference
Yanni Zhu
1 reference
G Mani Subramanian
1 reference
Diana M Brainard
1 reference
John G McHutchison
1 reference
Norbert Bräu
1 reference
Kosh Agarwal
1 reference
Bal Raj Bhandari
1 reference
Mitchell Davis
1 reference
Jordan J Feld
1 reference
Alexander J Thompson
1 reference
Tarik Asselah
1 reference
Stuart K Roberts
1 reference
Graham R Foster
1 reference
5 April 2017
1 reference
1 reference
153
1 reference
1
1 reference
113-122
1 reference
Identifiers
1 reference
1 reference